Dosing Interval Flexibility: Clinical Evidence and Individual Variation Research on GLP-1 timing suggests that injections within a 24-48 hour window of the scheduled day typically maintain therapeutic consistency
Oncogenic G protein GNAQ induces uveal melanoma and intravasation in mice
A key mediator of neurodegeneration in PD is synuclein overexpression, inflammation, mitochondrial dysfunction, and apoptosis, which are protected from Mucuna pruriens and its constituent compound, ursolic acid
The news about how well retatrutide works came this month from Eli Lilly, the drugs manufacturer
Neurochem Int (1991) 18(2):21520
Understanding why Epithalon works, what it actually does inside the cell, and who benefits most from it requires looking past the longevity marketing language that now surrounds it and reading the science directly